Société Anonyme pour I'Etude et;L'Air Liquide; Société Anonyme pour IEtude et;LAir Liquide
发明人:
Baptiste BESSIERE,Jan Pype,Guy Simonnet
申请号：
US13647495
公开号：
US20130095194A1
申请日:
2012.10.09
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention relates to a gaseous inhalable medicament containing xenon or N2O as active ingredient for use by inhalation for preventing and/or for treating neuropathic pain or pains caused by at least one cancer chemotherapy substance administered to a patient suffering from cancer, in particular a patient suffering from breast cancer, lung cancer, ovarian cancer, prostate cancer, colon cancer, rectal cancer or a gastric cancer or cancer of the upper aerodigestive tracts. The cancer chemotherapy substance contains one or more compounds chosen from platinum salts, taxanes, alkaloids, thalidomide and bortezomib, in particular paclitaxel, docetaxel or oxaliplatin. The effective volume proportion of nitrous oxide or of xenon is between 5 and 70%.
